DIANA GOMEZ: Open Payments
NPI 1043669880 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 8 payments from 4 companies in 2025. Trend: 2023 $54 · 2024 $190 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $383 |
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 2 | $68 |
Products named: VRAYLAR, INGREZZA, FANAPT, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
